Doctorsa raises €1M seed to expand its on-demand telemedicine network for travellers

Doctorsa, a Milan-based telemedicine startup founded in 2023 by Nadia Neytcheva and Francesco Maria Serino, has raised €1 million in a Seed round led by PranaVentures, with Vento and 40Jemz Ventures participating. The capital funds international expansion, B2B distribution partnerships with travel companies and insurers, and investment in AI-powered booking infrastructure.

Doctorsa connects travellers — people who become unwell or injured outside their home country — with verified local doctors via video consultation, in minutes. The network currently covers 550+ doctors in 40 countries and supports cross-border prescriptions where local law permits. A traveller in Barcelona who needs a consultation does not speak to a home-country doctor via remote video; they speak to a local physician who knows local pharmacies, local healthcare infrastructure, and the local regulatory environment for prescriptions.

The structural gap in travel health

Standard telemedicine platforms are designed for at-home use. They connect users to practitioners licensed in the user's home jurisdiction, which creates a legal and practical barrier when the user is abroad: the home practitioner cannot prescribe locally, may not know the local pharmacy system, and cannot assist with in-person follow-up if the situation deteriorates. Travel insurance medical assistance lines offer emergency coordination but typically require the insurer's own medical team as an intermediary.

Doctorsa's model bypasses this by owning the local network directly. Whether the company can maintain quality standards at scale — across 550+ doctors in 40 countries — while expanding further is the operational challenge behind the product ambition. Medical network curation is not a problem that technology alone solves.

B2B as the distribution lever

The company's priority is building a B2B channel alongside its direct-to-consumer offering. Travel companies, insurers, and employers with mobile workforces are natural buyers: they already sell travel health products or carry medical assistance obligations and can distribute Doctorsa as an embedded service rather than requiring travellers to discover and subscribe independently. B2B distribution is structurally more capital-efficient than consumer acquisition at the stage Doctorsa is at, and partnership contracts provide revenue visibility that a subscription model to individual travellers does not. The AI booking infrastructure investment suggests the company is also working to reduce the operational cost per consultation as it scales.